RTW Investments, LP 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-16 7:51 pm Purchase | 2024-12-12 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 18,401,313 17.600% | 212,856 (+1.17%) | Filing |
| 2023-09-19 4:15 pm Unchanged | 2023-09-15 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 18,188,457 20.320% | 0 (Unchanged) | Filing |
| 2023-04-05 4:31 pm Purchase | 2022-12-01 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 18,188,457 23.000% | 559,890 (+3.18%) | Filing |
| 2022-10-11 4:30 pm Purchase | 2022-10-06 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 17,628,567 24.400% | 1,355,932 (+8.33%) | Filing |
| 2022-09-21 09:00 am Unchanged | 2022-09-19 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 16,272,635 24.600% | 0 (Unchanged) | Filing |
| 2021-08-31 5:08 pm Purchase | 2021-05-11 | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW Investments, LP | 16,272,635 25.300% | 87,516 (+0.54%) | Filing |